Services
Publications
Contact Us
Publications

  1. Zagaria ME. Lumbar spinal stenosis. US Pharm. 2011;36(3):20-23.
  2. Zagaria ME. Antipsychotic-associated metabolic and cardiovascular risks: Monitoring and risk-reduction strategies. Amer J for Nurse Practitioners. 2011;15(3/4):ahead of print.
  3. Zagaria ME. Aortic stenosis: Evidence supports surgery. US Pharm. 2011;36(2):20-25.
  4. Zagaria ME. Collaborative patient care for seniors with pain. US Pharm. 2011;36(1):21-25.
  5. Zagaria ME. Topical corticosteroids: Focus on appropriate potency and vehicle. Amer J for Nurse Practitioners. 2010;14(11/12):36-40.
  6. Zagaria ME. Gallstones: Aging and medications increase risk. US Pharm. 2010;35(12):21-24.
  7. Zagaria ME. Common adverse effects of antipsychotic agents in the elderly. US Pharm. 2010;35(11):22-26.
  8. Zagaria ME. Preventing pneumonia in seniors. US Pharm. 2010;35(10):22-25.
  9. Zagaria ME. Sarcopenia: Loss of muscle mass in older adults. US Pharm. 2010;35(9): 24-30.
  10. Zagaria ME. Vitamin deficiencies in seniors. US Pharm. 2010;35(8): 20-27.
  11. Zagaria ME. Post-Stroke aspiration pneumonia. US Pharm. 2010;35(7): 20-24.
  12. Zagaria ME. Subclinical hypothyroidism. US Pharm. 2010;35(6): 20-22.
  13. Zagaria ME. Chronic opioid therapy for noncancer pain. US Pharm. 2010;35(5): 20-24.
  14. Zagaria ME. Medications and conditions that potentiate heatstroke: Focus on seniors. Amer J for Nurse Practitioners. 2010;14(5):35-40.
  15. Zagaria ME. Kaposi’s Sarcoma: Prognosis varies with form. US Pharm. 2010;35(4):20-23.
  16. Zagaria ME. Hot flashes and night sweats. US Pharm. 2010;35(3): 20-24.
  17. Zagaria ME. Inhalant agents for asthma, bronchospasm, and COPD: Focus on delivery devices and inhalation technique. Amer J for Nurse Practitioners. 2010;14(3):21-25.
  18. Zagaria ME. Warfarin in seniors: Reducing Likelihood of harm. US Pharm. 2010;35(2): 2-22.
  19. Zagaria ME. Common causes of drug-induced seizures. US Pharm. 2010;35(1): 20-23.
  20. Zagaria ME. Colorectal cancer screening. US Pharm. 2009;34(12): 29-31.
  21. Zagaria ME. Progressive supranuclear palsy. US Pharm. 2009;34(11): 20-22.
  22. Zagaria ME. The dying patient: Choices, control, and communication – End-of-Life Care. US Pharm. 2009;34(10): 32-34.
  23. Zagaria ME. Dyslipidemia: Benefits and risks of statins in primary prevention. Amer J for Nurse Practitioners. 2009;13(10):16-22.
  24. Zagaria ME. Obesity: Reality and relevance to health. US Pharm. 2009;34(9): 20-24.
  25. Zagaria ME. Amyloidosis: Interference with organ structure and function. US Pharm. 2009;34(8): 21-24.
  26. Zagaria ME. Renal dosing: Understanding glomerular filtration rate and estimating creatinine clearance. Amer J for Nurse Practitioners. 2009;13(7/8)32-35.
  27. Zagaria ME. Raising awareness about pulmonary embolism: Risk and misdiagnosis. US Pharm. 2009;34(7): 24-26.
  28. Zagaria ME. Caring for the aging: Key health care legislation. US Pharm. 2009;34(6): 22-24.
  29. Zagaria ME. Assessing pain in the cognitively impaired. US Pharm. 2009;34(5):21-25.
  30. Zagaria ME. High-alert medications: Resources for NPs. Amer J for Nurse Practitioners. 2009;13(5):21-28.
  31. Zagaria ME. Dermatologic signs of rheumatoid arthritis: Joint and systemic symptoms. US Pharm. 2009;34(4): 22-24.
  32. Zagaria ME. Vitamin D deficiency and bone pain: Osteomalacia. US Pharm. 20009;34(3): 22-24.
  33. Zagaria ME. Medication-related problems in seniors: Risk factors and tips for appropriate prescribing. Amer J for Nurse Practitioners. 2009;13(3):23-27.
  34. Zagaria ME. Venous Thrombosis. US Pharm. 2009;34(2): 22-24.
  35. Zagaria ME. Wrist and thumb pain in seniors: Focus on De Quervain’s tenosynovitis. US Pharm. 2009;34(1): 20-22
  36. Zagaria ME. Contrast-Induced Nephropathy. US Pharm. 2008;33(12):20-22.
  37. Zagaria ME. Antipsychotics in seniors: Warnings to prevent misuse. US Pharm. 2008;33(11):20-22. 
  38. Zagaria ME. ACE inhibitors in hypertension: Dosing, comparisons, and compelling indications. Amer J for Nurse Practitioners. 2008;12(11):26-32. 
  39. Zagaria ME. Nebivolol: New beta-blocker for hypertension. US Pharm. 2008;33(10):20-26. 
  40. Zagaria ME. Health literacy: Striving for effective communication. Amer J for Nurse Practitioners. 2008;12(9):23-26. 
  41. Zagaria ME. Postmenopausal vaginal bleeding. US Pharm. 2008;33(9):28-32.
  42. Zagaria ME. Sexual activity and STDs among seniors. US Pharm. 2008;33(8):28-30. 
  43. Zagaria ME. Tuberculosis: A preventable cause of death in the elderly. US Pharm. 2008;33(7):23-25.
  44. Zagaria ME. Unintentional acetaminophen overdose: Focus on prevention. Amer J for Nurse Practitioners. 2008;12(6):47-51. 
  45. Zagaria ME. Baby boomers on brink of healthcare crisis. US Pharm. 2008;33(6):20-26. Zagaria ME. Consequences of persistent pain. US Pharm. 2008;33(5):28-30.
  46. Zagaria ME. Relapsing-remitting multiple sclerosis: Primary and symptomatic management. Amer J for Nurse Practitioners. 2008;12(4):22-26. 
  47. Zagaria ME. Cutaneous adverse reactions: Stevens-Johnson syndrome. US Pharm. 2008;33(4):20-26
  48. Zagaria ME. Diverticulitis: Overview and management. US Pharm. 2008;33(3):22-25.
  49. Zagaria ME. Adverse drug effects: Focus on SSRIs. Amer J for Nurse Practitioners. 2008;12(3):34-38.
  50. Zagaria ME. Warfarin and adverse effects. US Pharm. 2008;33(2):22-25.
  51. Zagaria ME. Causes of seizures in the elderly. US Pharm. 2008;33(1):27-31.
  52. Zagaria ME. Pediatric GER & GERD: Overview and management. Amer J for Nurse Practitioners. 2008;12(1):36-42.
  53. Zagaria ME. GERD update: The refractory patient. US Pharm. 2007;32(12):20-23.
  54. Zagaria ME. Serotonin syndrome. US Pharm. 2007;32(11):20-23.
  55. Zagaria ME. Seniors and drug development: Encouraging better communication. US Pharm. 2007;32(10):20-25 .
  56. Zagaria ME. Atypical antipsychotic agents: Monitoring for metabolic syndrome. Amer J for Nurse Practitioners. 2007;11(10):20-26.
  57. Zagaria ME. Screening for dementia in older females. US Pharm. 2007;32(9):20-25.
  58. Zagaria ME. Anticholinergic adverse effects. Amer J for Nurse Practitioners. 2007;11(9):20-25.
  59. Zagaria ME. Depression: Suicide’s primary remediable risk factor. US Pharm. 2007;32(8):22-27. .
  60. Zagaria ME. Pneumoccal Vaccine: Protecting Seniors from Pneumonia. US Pharm. 2007;32(7):22-29.
  61. Zagaria ME. Seniors at Risk for Delirium. US Pharm. 2007;32(6):20-24.
  62. Zagaria ME.. A Healthy Tan? Think Again. US Pharm Student Edition. Summer 2007.
  63. Zagaria ME. Geriatric Palliative Care: When the Focus Shifts From Care to Comfort. US Pharm. 2007;32(5):28-34.
  64. Zagaria ME. Chronic and Acute Effects of Sun Exposure on the Skin. US Pharm. 2007;32(4):20-26.
  65. Zagaria ME. Generic Medications: Issues in Senior Care Pharmacy. US Pharm Generic Drug Review. June 2007:14-15.
  66. Zagaria ME. Rate Control in Atrial Fibrillation. US Pharm. 2007;32(2):32-38.
  67. Zagaria ME. Vision, Cognition, and Mobility Challenges for Elderly Drivers. US Pharm. 2007;32(1):36-40.
  68. Zagaria ME. Family Caregiving: Seniors Continue to Receive and Deliver Care. US Pharm. 2006;31(12):23-29.
  69. Zagaria ME. Low Health Literacy: A Safety Concern Among the Elderly. US Pharm. 2006;31(10):28-34.
  70. Zagaria ME. Polypharmacy and Potentially Inappropriate Medication Use in he Elderly: Across the Practice-Setting Spectrum. US Pharm. 2006;31(10):112-116.
  71. Zagaria ME. Persistent Urinary Incontinence in Older Women: Treatment Can Improve Quality of Life. US Pharmacist 2006;31(9):20-34.
  72. Zagaria ME. Depression in Older Male Patients. US Pharmacist 2006;31(8):34-40.
  73. Zagaria ME. Management of COPD in Seniors. US Pharmacist 2006;31(7):28-34.
  74. Zagaria ME. Heat-Related Illnesses in Older Adults: Identifying Potentially Lethal Conditions. US Pharmacist 2006;31(6):34-38.
  75. Zagaria ME. Pain Assessment in Older Adults: The Cornerstone of Controlling Pain. US Pharmacist 2006;31(5):30-36
  76. Zagaria ME. Xerosis: Treating Clinically Dry Skin. US Pharmacist 2006;31(4):28-32.
  77. Zagaria ME. Parkinson’s Disease: Key Points for the Pharmacist. US Pharcist. 2006;31(3):20-30.
  78. Zagaria ME. Special Considerations for Lowering Lipids in Seniors. US Pharmacist 2006;31(2):20-27.
  79. Zagaria ME. Osteoarthritis in Seniors. US Pharmacist 2006;31(1):20-24.
  80. Zagaria ME. Sleep Disorders in Senior Women: Diagnosing and Treating a Common Complaint. Women’s Health in Psychiatry. 2006;2(1):14-23.
  81. Zagaria ME. Traumatic Brain Injury in the Elderly. US Pharmacist 2005;30(12):20-26.
  82. Zagaria ME. Age-Related Macular Degeneration in the Elderly. US Pharmacist 2005;30(11):30-36.
  83. Zagaria ME. Suppressing Gastric Acid in Seniors with GERD. US Pharmacist 2005;30(10):34-39.
  84. Zagaria ME. Sleep Disturbances in Older Women: Diagnosing and Treating a Common Complaint. Women’s Health in Primary Care. September 2005;8(8):379-386.
  85. Zagaria ME, Buonanno AP. A Patient-Oriented Approach to the Management of Allergic Rhinitis. Power-Pak C.E. Jobson Publishing Group. September 2005.
  86. Zagaria ME. Vaginal Bleeding in Postmenopausal Women. US Pharmacist 2005;30(9):22-26.
  87. Zagaria ME. OTC Medication Use in Seniors. US Pharmacist 2005;30(8):24-26.
  88. Zagaria ME. Tips for Traveling Seniors. US Pharmacist 2005;30(7):32-36.
  89. Zagaria ME. Altered Sleep in Seniors. US Pharmacist 2005;30(6):32-38.
  90. Zagaria ME. The Effects of Aging on Drug Efficacy. US Pharmacist 2005;30(5):54-57.
  91. Zagaria ME. Medication Therapy Management Services. US Pharmacist 2005;30(4):35-42.
  92. Zagaria ME. Abnormal Blood Pressure Homeostasis. US Pharmacist 2005;30(3):29-33
  93. Zagaria ME. Geriatric Syndromes. US Pharm. 2005;30(2):29-34.
  94. Zagaria ME. Implications of Dysphagia. US Pharm. 2005;30(1):30-39.
  95. Cooper CB, Zagaria, ME. New Advances in the Management of COPD. Accreditation Council for Pharmacy Education. Program Number: 809-999-05-001-H01. January 2005.
  96. Perfetto E, Barber A, Atkinson W, Zagaria ME. Monitoring and Evaluation: Demonstrating Improved Care Processes and Patient Outcomes. In: Developing a Senior Care Pharmacy Practice: Your Guide and Tools for Success. 2004. American Society of Consultant Pharmacists. 2004: 123-132
  97. Zagaria ME, Feldman S. Introduction. In: Developing a Senior Care Pharmacy Practice: Your Guide and Tools for Success. 2004. American Society of Consultant Pharmacists. 2004: 5-11.
  98. Zagaria ME. Herpes Zoster, or Shingles, is Painful: Increased Risk in Seniors. US Pharm. 2004;29(12):33-38.
  99. Zagaria ME. Risk in Clinical Trials Versus Clinical Practice: Drug-Induced Hyperkalemia. US Pharm. 2004;11:29-34
  100. Zagaria ME. Low Health Literacy: Raising Awareness for Optimal Health Communication. US Pharm. 2004;29(10):41-48
  101. Zagaria ME. Carpal Tunnel Syndrome: A Major Entrapment Neuropathy in the Elderly. US Pharm. 69. 2004;29(9):30-36
  102. Zagaria ME. Prevention of Prostate Cancer: Study Investigates Vitamin E and Selenium. US Pharm. 2004;29(8):32-38.
  103. Zagaria ME. Managing the Elderly with Stable COPD. US Pharm. 2004;29(7):32-38.
  104. Zagaria ME. Pharmacoeconomics in Senior Care: Balancing Costs and Outcomes. US Pharm. 2004;29(6):32-37.
  105. Zagaria ME. Insomnia, Depression, and Suicide Risk in the Elderly. US Pharm. 2004;29(5):30-37
  106. Zagaria ME. Superficial Fungal Infections: Considerations in Treatment Plans. US Pharm. 2004;29(4):20-24.
  107. Zagaria ME. Seniors as Caregivers. US Pharm. 2005;29(3):16-25.
  108. Zagaria ME. Recommended screenings for older adults. Modern Pharmacy June 2004;11(6):6-7.
  109. Zagaria ME. Hearing loss in the elderly. Modern Pharmacy June 2004;11(6):8-10.
  110. Zagaria ME. Aspirin Resistance. US Pharmacist 2004;29(2):41-46.
  111. Zagaria ME. The Promise of Pharmacogenomics. US Pharmacist 2004;29(1):31-36.
  112. Zagaria ME. Sexually Transmitted Diseases in Older Adults. US Pharmacist 2003;28(12):26-29.
  113. Zagaria ME. Hyperglycemia Due to Atypical Antipsychotics. US Pharmacist 2003;28(11):20-23.
  114. Zagaria ME. Transient Ischemic Attacks. US Pharmacist 2003;28(10):28-31.
  115. Zagaria ME. Dizziness and Vertigo in Seniors. US Pharmacist 2003;28(9):28-32.
  116. Zagaria ME. Benign Prostatic Hyperplasia. US Pharmacist 2003;28(8):28-34.
  117. Zagaria ME. Common Tremors in the Elderly. Modern Pharmacy 2003;10(8):22-24
  118. Zagaria ME. Aspiration Pneumonia. US Pharmacist 2003;28(7):28-33.
  119. Zagaria ME. Hemorrhoids: Treatment Options. US Pharmacist 2003;28(6):28-33.
  120. Zagaria ME. Drug-Induced Acute Renal Failure: Nonsteroidal Anti-Inflammatory Drugs. US Pharmacist 2003;28(5):19-23.
  121. Zagaria ME. Drug-Induced Acute Renal Failure: Angiotensin II Converting Enzyme Inhibitors and Receptor Blockers. US Pharmacist 2003;28(4):29-33.
  122. Zagaria ME. Lumbar Spinal Stenosis. US Pharmacist 2003;28(3):28-30.
  123. Zagaria ME. Hearing Loss in the Elderly. US Pharmacist 2003;28(2):13-15.
  124. Zagaria ME. End-of-Life Care in the Elderly. US Pharmacist 2003;28(1):20-23.
  125. Zagaria ME. Legal Aspects of Eldercare: The Living Will, Healthcare Proxy and Do-Not-Resuscitate (DNR) Order. US Pharmacist 2002;27(12):68-69.
  126. Zagaria ME. Appropriate Monitoring Parameters for Epoetin Alfa Therapy for Anemia Associated with Chronic Renal Failure (CRF). US Pharmacist 2002;27(11):52-54.
  127. Zagaria ME. Postherpetic Neuralgia. US Pharmacist. 2002; 27(10): 21-23.
  128. Zagaria ME. Visual Consequences of the Aging Eye: Falls and Driving Accidents Among Seniors. US Pharmacist. 2002; 27(8): 33-36.
  129. Zagaria ME. Senior Health Maintenance Part II: Cognitive and Nutritional Fitness. US Pharmacist. 2002; 27(7): 21-23.
  130. Zagaria ME. Senior Health Maintenance Part I: Exercise. US Pharmacist. 2002; 27(6): 35-38.
  131. Zagaria ME. Disinhibition as a Complication of Benzodiazepine Therapy. US Pharmacist. 2002; 27(5): 37-41.
  132. Zagaria ME. Recommended Screenings for Older Adults. US Pharmacist. 2002; 27(3): 37-41.
  133. Zagaria ME. Common Tremors in the Elderly: Symptom or Side Effect? US Pharmacist. 2002; 27(1): 23-28.
  134. Zagaria ME. The Elderly Diabetic and Autonomic Neuropathy. US Pharmacist. 2001; 26(11): 28-31.
  135. Zagaria ME. Urinary Incontinence: Care, Complications, and Cost. US Pharmacist. 2001; 26(10): 28-33.
  136. Zagaria ME. Osteoporosis and Prediction of Fracture Risk. US Pharmacist. 2001; 26(09): 28-39.
  137. Zagaria ME. Sciatica in Older Adults. US Pharmacist. 2001; 26(08): 41-46.
  138. Zagaria ME. New Guidelines for Cholesterol Management. US Pharmacist. 2001; 26(07): 29-33.
  139. Zagaria ME. Pharmacist Interventions Can Prevent Falls. US Pharmacist. 2001; 26(05): 79-81.
  140. Zagaria ME. TIA, Stroke, and the Importance of Post-Stroke Rehabilitation. US Pharmacist. 2001; 26(02): 39-40.
  141. Zagaria ME. Alzheimer’s Disease: Focus on Early Diagnosis and Treatment. US Pharmacist. 2001; 26(01): 36-40.
  142. Zagaria ME. Gestational Diabetes Mellitus: Risks, Complications, and Therapeutic Outcomes. US Pharmacist. 2000; 25(11): 50-56.
  143. Zagaria ME. Nutrition in the Elderly: Undernutrition Perpetuates the Process of Physical, Cognitive, and Functional Decline. US Pharmacist. 2000; 25(10): 42-44.
  144. Zagaria ME. Temporal Arteritis: When Headache Can Lead to Blindness. US Pharmacist . 2000; 25 (9): 78-79
  145. Zagaria ME. Actinic Keratosis: Sun Exposure and Cancer Risk. US Pharmacist. 2000; 25 (8): 25-25
  146. Zagaria ME. Avoiding Adverse Effects in the Elderly. US Pharmacist. 2000; 25 (6): 73
  147. Zagaria ME. Insomnia in the Elderly. US Pharmacist. 2000; 25 (5): 81
  148. Zagaria ME. Depression: An Under treated Illness. US Pharmacist. 2000; 25 (4) 111
  149. Zagaria ME. Pain Management. US Pharmacist. 2000; 25 (3) 70-73
  150. Zagaria ME. Pharmaceutical Care of the Older Patient. US Pharmacist. 2000; 25(2): 94-97
  151. Zagaria ME. Quality of Life: Issues for the Pharmacist. American Pharmacy. 1995; NS35:52-58

 

Home | Bio | Services | Publications | Contact Us